Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PHF8 | Q9UPP1 | 6/20 | 0.65 |
| ▸ | KDM2A | Q9Y2K7 | 6/20 | 0.65 |
| ▸ | EGLN1 | Q9GZT9 | 5/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.65 |
| ▸ | KDM5C | P41229 | 4/20 | 0.65 |
| ▸ | KDM6B | O15054 | 2/20 | 0.65 |
| ▸ | LMNA | P02545 | 4/20 | 0.60 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.60 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.60 |
| ▸ | GABRR1 | P24046 | 1/20 | 0.55 |
| ▸ | ACE | P12821 | 1/20 | 0.52 |
| ▸ | LDHA | P00338 | 1/20 | 0.50 |
| ▸ | SRR | Q9GZT4 | 1/20 | 0.50 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.48 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | SLC13A3 | Q8WWT9 | 1/20 | 0.45 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.45 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30572348 | 1.00 | PHF8 (0.65) | PHF8KDM2AEGLN1KDM4EKDM5C | |
| SCHEMBL20377444 | 0.97 | PHF8 (0.62) | PHF8KDM2AEGLN1KDM4EKDM5C | |
| SCHEMBL20377423 | 0.97 | PHF8 (0.62) | PHF8KDM2AEGLN1KDM4EKDM5C | |
| SCHEMBL20377434 | 0.97 | PHF8 (0.62) | PHF8KDM2AEGLN1KDM4EKDM5C | |
| Ammonia Solution, Strong SCHEMBL20377426 | 0.97 | PHF8 (0.62) | PHF8KDM2AEGLN1KDM4EKDM5C | |
| SCHEMBL20377443 | 0.97 | PHF8 (0.62) | PHF8KDM2AEGLN1KDM4EKDM5C | |
| SCHEMBL6914036 | 0.97 | PHF8 (0.62) | PHF8KDM2AEGLN1KDM4EKDM5C | |
| SCHEMBL20377429 | 0.97 | PHF8 (0.62) | PHF8KDM2AEGLN1KDM4EKDM5C | |
| SCHEMBL20377438 | 0.97 | PHF8 (0.62) | PHF8KDM2AEGLN1KDM4EKDM5C | |
| Hydrogen Sulfide SCHEMBL28240428 | 0.97 | PHF8 (0.62) | PHF8KDM2AEGLN1KDM4EKDM5C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1003 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3346011-B1 | HOST CELLS FOR PREPARING ADIPATE (ESTER OR THIOESTER) | GENOMATICA INC (US) | 2026-05-20 | — | — | EP | claimed |
| US-12606852-B2 | Conversion of lignin-derived monomers to muconate by engineered pseudomonas | Alliance for Energy Innovation, LLC (US) | 2026-04-21 | — | — | US | claimed |
| US-20260028651-A1 | METHOD OF PRODUCING & PROCESSING DIAMINES | AGAIN BIO APS (DK) | 2026-01-29 | — | — | US | claimed |
| US-20260021186-A1 | Fatty Acid-D-Amino Acid Peptides Conjugates as Anaplerotic Compounds for Use in Treating Propionic Acidemia, Methylmalonic Acidurias, and Energy Metabolic Disorders | UNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION (US) | 2026-01-22 | — | — | US | claimed |
| US-12503711-B2 | Method of producing and processing diamines to a diamine free base using a carbonate intermediate and an engineered microorganism | GENOMATICA, INC. (US) | 2025-12-23 | — | — | US | claimed |
| EP-4642908-A2 | LIGASE AND DEHYDROGENASE VARIANTS AND METHODS OF USE | Genomatica, Inc. (US) | 2025-11-05 | — | — | EP | claimed |
| US-20250215461-A1 | GENETICALLY MODIFIED MICROORGANISM FOR PRODUCING 3-HYDROXYADIPIC ACID AND/OR 3-OXOADIPIC ACID, AND PRODUCTION METHOD FOR SAID CHEMICAL PRODUCTS | TORAY INDUSTRIES, INC. (JP) | 2025-07-03 | — | — | US | claimed |
| EP-4565325-A2 | FATTY ACID-D-AMINO ACID PEPTIDES CONJUGATES AS ANAPLEROTIC COMPOUNDS FOR USE IN TREATING PROPIONIC ACIDEMIA, METHYLMALONIC ACIDURIAS, AND ENERGY METABOLIC DISORDERS | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2025-06-11 | — | — | EP | claimed |
| CN-119855613-A | Fatty acid-D-amino acid peptide conjugates as anaplerotic compounds for the treatment of hyperuricemia, methylmalonic urine disorder and energy metabolism disorders | 匹兹堡大学高等教育联邦体系 | 2025-04-18 | — | — | CN | claimed |
| EP-4497819-A1 | GENETICALLY-MODIFIED MICROORGANISM FOR PRODUCING 3-HYDROXYADIPIC ACID AND/OR 3-OXOADIPIC ACID AND PRODUCTION METHOD FOR SAID CHEMICAL PRODUCTS | Toray Industries, Inc. (JP) | 2025-01-29 | — | — | EP | claimed |
| US-20060020141-A1 | Metallized dye | XEROX CORPORATION | 2006-01-26 | — | — | US | claimed |
| US-6989052-B1 | Phase change ink printing process | XEROX CORPORATION (US) | 2006-01-24 | — | — | US | claimed |
| US-20060004123-A1 | PHASE CHANGE INK PRINTING PROCESS | XEROX CORPORATION | 2006-01-05 | — | — | US | claimed |
| US-6946025-B2 | Process for preparing tetra-amide compounds | XEROX CORPORATION (US) | 2005-09-20 | — | — | US | claimed |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | XEROX CORPORATION | 2005-04-28 | — | — | US | claimed |
| EP-1041154-B1 | Process for the preparation of 5-aminolevulinic acid | COSMO RES INST (JP) | 2003-03-12 | — | — | EP | claimed |
| EP-1041154-A1 | 5-Aminolevulinic acid producing microorganism and process for producing 5-aminolevulinic acid | COSMO RESEARCH INSTITUTE (JP) | 2000-10-04 | — | — | EP | claimed |
| US-5763235-A | PHOTOSYNTHETIC BACTERIUM WHICH PRODUCES 5-AMINOLEVULINIC ACID WITHOUT LIGHT IRRADIATION | COSMO RESEARCH INSTITUTE (JP) | 1998-06-09 | — | — | US | claimed |
| EP-0718405-A2 | 5-Aminolevulinic acid producing microorganism, and process for producing it | COSMO RESEARCH INSTITUTE (JP) | 1996-06-26 | — | — | EP | claimed |
| EP-0074169-B1 | MICRO-BIOLOGICAL PRODUCTION OF MUCONIC ACID | CELANESE CORPORATION (US) | 1987-01-14 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250215461-A1 | GENETICALLY MODIFIED MICROORGANISM FOR PRODUCING 3-HYDROXYADIPIC ACID AND/OR 3-OXOADIPIC ACID, AND PRODUCTION METHOD FOR SAID CHEMICAL PRODUCTS | HMGCR, GNPAT, COASY | PHF8 3620/4885KDM2A 3817/4885EGLN1 3294/4885 |
| US-20260028651-A1 | METHOD OF PRODUCING & PROCESSING DIAMINES | DDC, DAO, ODC1 | PHF8 1447/4885KDM2A 1724/4885EGLN1 479/4885 |
| US-20060020141-A1 | Metallized dye | CDYL, CDY1; CDY1B, CDYL2 | PHF8 2309/4885KDM2A 1765/4885EGLN1 4717/4885 |
| US-20260021186-A1 | Fatty Acid-D-Amino Acid Peptides Conjugates as Anaplerotic Compounds for Use in Treating Propionic Acidemia, Methylmalonic Acidurias, and Energy Metabolic Disorders | HADHB, HADHA, HADH | PHF8 2148/4885KDM2A 2091/4885EGLN1 332/4885 |
| US-12606852-B2 | Conversion of lignin-derived monomers to muconate by engineered pseudomonas | P4HB, COASY, HPD | PHF8 545/4885KDM2A 254/4885EGLN1 421/4885 |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | TAF9, TAF5, TAF1 | PHF8 1523/4885KDM2A 1744/4885EGLN1 3980/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.